Domain Partners VI L.P. 13D/13G Filings for Marinus Pharmaceuticals, Inc. (MRNS)

Domain Partners VI L.P. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-09-29
4:49 pm
Purchase
2020-09-2913DMarinus Pharmaceuticals, Inc.
MRNS
Domain Partners VI L.P.619,221
2.000%
619,221increase
(New Position)
Filing